Patel, Atul K <br/><br/>
Effectiveness of low-dose indinavir/ritonavir at 400/100 mg twice a day with 2 nucleoside reverse transcriptase inhibitors in nonnucleoside reverse transcriptase inhibitor-experienced HIV-infected patients in India: 1-year follow-up.  [electronic resource] 

 -  Journal of acquired immune deficiency syndromes (1999)  Sep 2006 
 - 123-6 p.  digital 
<br/><br/> Publication Type: Letter 
<br/><br/><label>ISSN: </label>1525-4135 
<br/><br/><label>Standard No.: </label>10.1097/01.qai.0000230522.86964.5d  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>CD4 Lymphocyte Count<br/>Cohort Studies<br/>Female<br/>Follow-Up Studies<br/>HIV Infections--drug therapy<br/>Humans<br/>India<br/>Indinavir--therapeutic use<br/>Male<br/>Middle Aged<br/>Reverse Transcriptase Inhibitors--therapeutic use<br/>Ritonavir--therapeutic use